Q1 2021
Released Apr 28, 2021, after the close
10-Q filed Apr 29, 2021, 29 days after period end · 0001653477-21-000045
Q1 2021 · 10-Q
Revenue$320.30M$320.30M +11.1% vs Q1 2020−1.6% vs Q4 2020
Net Income$48.70M$48.70M +7.5% vs Q1 2020+5.9% vs Q4 2020
EPS Diluted$1.20$1.20 +11.1% vs Q1 2020+8.1% vs Q4 2020
Gross Profit$126,200,000+10.1%
Operating Income$105,400,000+14.3%
Operating Cash Flow$51,100,000−15.1%
Free Cash Flowderived$34,100,000−16.2%
Margins · derived
Gross margin39.4%−0.4 pt vs Q1 2020
Operating margin32.9%+0.9 pt vs Q1 2020
Net margin15.2%−0.5 pt vs Q1 2020
What the release said
The release
Same quarter
| Metric | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|
| Revenue | $320.30M | $288.20M | $276.80M | $235.20M |
| Net Income | $48.70M | $45.30M | $22.70M | $30.80M |
| EPS Diluted | $1.20 | $1.08 | $0.54 | $0.72 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR